Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?

被引:26
|
作者
Reichman, David E. [1 ]
Chung, Pak [1 ]
Meyer, Laura [1 ]
Greenwood, Eleni [2 ]
Davis, Owen [1 ]
Rosenwaks, Zev [1 ]
机构
[1] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med Ctr, New York, NY 10021 USA
关键词
IVF; consecutive cycles; time interval; OVARIAN HYPERSTIMULATION SYNDROME; GNRH ANTAGONIST; LUTEAL SUPPORT; STIMULATION; PROTOCOL; AGONIST; TRIGGER;
D O I
10.1016/j.fertnstert.2012.11.044
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether patients who failed an in vitro fertilization (IVF) cycle can proceed with a subsequent IVF cycle after waiting only one menstrual cycle, or whether there is a benefit to allowing two or more menstrual cycles to elapse before proceeding. Design: Retrospective cohort study. Setting: Academic medical center. Patient(s): All patients undergoing IVF cycles at The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, from January 1, 2002 to November 1, 2011, in whom two consecutive gonadotropin-releasing hormone (GnRH)-antagonist IVF cycles with identical stimulation protocols took place 35-140 days apart, excluding patients in whom the first cycle resulted in a clinical pregnancy. Intervention(s): None. Main Outcome Measure(s): IVF outcomes were compared for 164 patients who initiated a cycle after waiting only one menstrual cycle (35-55 days from previous oocyte retrieval) versus 557 patients waiting two or more menstrual cycles (56-140 days) from their last retrieval before proceeding with their successive cycle start, stratifying for age. Result(s): No differences were detected regarding E-2 response, oocyte yield, fertilization, or embryo development when comparing patients waiting only one cycle with those waiting two or more cycles, nor were those parameters different when comparing patients' index cycles with their immediate preceding failed cycles. Moreover, clinical outcomes regarding clinical pregnancy, live birth, and cycle cancellation were similar between both study groups. Conclusion(s): Delaying successive IVF cycle start for two or more menstrual cycles likely offers no advantage over pursuing repeated IVF after one menstrual cycle. (Fertil Steril (R) 2013; 99:1277-82. (C) 2013 by American Society for Reproductive Medicine.)
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 50 条
  • [21] Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes?
    Pereira, Nigel
    Amrane, Selma
    Estes, Jaclyn L.
    Lekovich, Jovana P.
    Elias, Rony T.
    Chung, Pak H.
    Rosenwaks, Zev
    FERTILITY AND STERILITY, 2016, 105 (02) : 539 - +
  • [22] Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles
    Meyer, Laura
    Murphy, Lauren A.
    Gumer, Arielle
    Reichman, David E.
    Rosenwaks, Zev
    Cholst, Ina N.
    FERTILITY AND STERILITY, 2015, 104 (03) : 637 - 642
  • [23] A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization
    Berin, Inna
    Stein, Daniel E.
    Keltz, Martin D.
    FERTILITY AND STERILITY, 2010, 93 (02) : 360 - 363
  • [24] Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration
    Propst, Anthony M.
    Hill, Micah J.
    Bates, Gordon Wright
    Palumbo, Michelle
    Van Horne, Anne K.
    Retzloff, Matthew G.
    FERTILITY AND STERILITY, 2011, 96 (04) : 898 - 904
  • [25] In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit, T.
    Ellenbogen, A.
    Michaeli, M.
    Kartchovsky, E.
    Ruzov, O.
    Shalom-Paz, E.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 179 : 46 - 50
  • [26] Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
    Chen, Liang-Hsuan
    Chin, Tzu-Hsuan
    Huang, Shang-Yu
    Yu, Hsing-Tse
    Chang, Chia-Lin
    Huang, Hong-Yuan
    Wang, Hsin-Shih
    Soong, Yung-Kuei
    Wu, Hsien-Ming
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2021, 60 (04): : 739 - 744
  • [27] Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles
    Jurema, MW
    Bracero, NJ
    Garcia, JE
    FERTILITY AND STERILITY, 2003, 80 (05) : 1156 - 1161
  • [28] Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments
    Louzada Maldonado, Luiz Guilherme
    Franco, Jose Goncalves, Jr.
    Setti, Amanda Souza
    Iaconelli, Assumpto, Jr.
    Borges, Edson, Jr.
    FERTILITY AND STERILITY, 2013, 99 (06) : 1615 - 1622
  • [29] Effect of Length of Controlled Ovarian Hyperstimulation Using a Gonadotropin-Releasing Hormone Antagonist on in Vitro Fertilization Pregnancy Rates
    Royster, G. Donald
    Retzloff, Matthew G.
    Robinson, Randal D.
    King, Jeremy A.
    Propst, Anthony M.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (9-10) : 415 - 420
  • [30] The effect of a transient premature luteinizing hormone surge without elevated serum progesterone on in vitro fertilization outcomes in a gonadotropin-releasing hormone antagonist flexible protocol
    Zhang, Duoduo
    Zhang, Dan
    Sun, Zhengyi
    Deng, Chengyan
    Yu, Qi
    Zhen, Jingran
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (06) : 550 - 553